Devlin Jodi 4
4 · TriSalus Life Sciences, Inc. · Filed May 21, 2025
Insider Transaction Report
Form 4
Devlin Jodi
Chief of Clinical Operations
Transactions
- Award
Common Stock
2025-05-19$5.18/sh+24,131$124,999→ 57,528 total - Sale
Common Stock
2025-05-19$5.18/sh−4,764$24,678→ 52,764 total
Footnotes (2)
- [F1]The granted RSUs vest immediately.
- [F2]The sale of the shares was to cover the tax liability associated with the granted RSUs.